Long-term course and effectiveness of combination therapy in Alzheimer disease - Wikidata - awgldk - TriplyDB

Long-term course and effectiveness of combination therapy in Alzheimer disease

Long-term course and effectiveness of combination therapy in Alzheimer disease

http://www.wikidata.org/entity/Q24642161

about

Diverse molecular targets for therapeutic strategies in Alzheimer's disease Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease Efficacy of memantine, donepezil, or their association in moderate-severe Alzheimer's disease: a review of clinical trials α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum The effectiveness and safety of acupuncture for patients with Alzheimer disease: a systematic review and meta-analysis of randomized controlled trials Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease Evaluation of traditional medicines for neurodegenerative diseases using Drosophila models In the Information Age, do dementia caregivers get the information they need? Semi-structured interviews to determine informal caregivers' education needs, barriers, and preferences A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease From single target to multitarget/network therapeutics in Alzheimer's therapy Current neuroimaging techniques in Alzheimer's disease and applications in animal models The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer).Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease Predicting progression of Alzheimer's disease.The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial.Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia Acupuncture for patients with Alzheimer's disease: a systematic review protocol.An overview of longitudinal data analysis methods for neurological research.Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies.Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.Efficacy and Tolerability of a Combination Treatment of Memantine and Donepezil for Alzheimer's Disease: A Literature Review Evidence.Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementia Predictors of long-term cognitive outcome in Alzheimer's disease Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer's dementia: a pooled area under the curve analysis Antidementia drug treatment in dementia networks in Germany: use rates and factors associated with treatment use.The Effects of Anti-Dementia and Nootropic Treatments on the Mortality of Patients with Dementia: A Population-Based Cohort Study in Taiwan Improving physician awareness of Alzheimer disease and enhancing recruitment: the Clinician Partners Program.Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.Alzheimer's disease: a clinical practice-oriented review.Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease.OPTIMIZING DIAGNOSIS AND MANANGEMENT IN MILD-TO-MODERATE ALZHEIMER'S DISEASE.Factors that influence survival in a probable Alzheimer disease cohort.Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy.

P2860

Q26827193-72D24DE3-BFF4-4465-BA9B-5B3F848FF70F Q26829899-F014560E-C35A-4240-8912-C642602316CE Q26851862-C6BB04D5-8C57-4C2A-81E8-EC5AA26F3B85 Q26852967-0FFFD6A8-005E-4AA8-A587-A6E8CA43AE82 Q27007532-05A2090C-FC23-46CD-ACC7-EC7D2E33B66D Q27025207-15B5AB5A-27BC-406C-9688-9B27D6445C8A Q27027455-EE4AF8D7-C466-40CA-A0E1-981486E04706 Q27312529-B006A052-8505-47EC-9BAB-AB8DD4692687 Q28076715-2AF58745-4972-492A-A6D8-D88FA133480C Q28658200-D5E4460C-4B8B-40DE-85B7-79B465BD7CE5 Q30576714-B0D62C9A-D43A-4D7C-9918-BEACD6198FA6 Q33165801-51AFF352-7F44-419C-BE21-111ABA123322 Q33454879-26A27DCD-CE94-4C67-AB19-72A203AD07ED Q33718205-7B1ABAA5-5B32-4FE1-BF4A-762081DEDAFE Q33801636-7607A9DE-117D-4CA6-A228-42CEFAB24E85 Q33867858-BACF4208-4D5D-42BF-8F9B-B35C244FC788 Q33867869-A1D628D9-804C-4BD0-9946-DE4221668A54 Q33869501-2950ED58-E182-403D-B885-7D8DF259601E Q33905343-DF9116B9-45DB-48FF-8ABA-526759B7C003 Q34071799-A308E23A-AB79-4F2A-9EA7-17BC0D95B783 Q34112927-FAD1C92E-7B39-489A-8D37-5B658836DC40 Q34156798-4581F656-EA43-4C4E-8B82-22858DFDE8FE Q34233759-C70C383F-83AC-4DB0-BA43-5DCCA1B22BC3 Q34245127-9A8E7FC7-776A-457E-A67B-3AC6B708092D Q34301111-29E4273F-726D-44D8-89B0-D5D03EE65C45 Q34327769-52583E94-440C-443E-B612-8A47740FC5DA Q34466802-18649312-98FD-4526-8556-FE21CE9E2ED2 Q34528182-8BE5556F-EA13-4967-9792-F81B7082F2E0 Q35251909-F19E517C-962F-4D2C-BF3A-DEB640EBC5E5 Q35579243-138EC6D7-1404-4487-BDEF-722C8DD2A99C Q35620305-EA884B48-B03C-4E57-811F-7A29C680AD30 Q35638635-DC52444A-5976-4181-BF51-923AD58AC41C Q35670849-EF8C3529-8D3C-4489-8C34-E5FFD0A49440 Q35784071-BEBB91FC-A31A-4D18-968B-EAC6E4094EFB Q35793076-5FB0968A-1ABB-4A41-B400-DE99D96BFB1F Q35899503-6D6B081B-ED0E-4A5C-B9AE-FD77365EEEB9 Q36013947-491E8CF6-19D2-4986-BBEE-1755F8EBD72D Q36221014-9E4455FD-2DC9-476E-8850-AF253353AF5C Q36424811-7CC83CED-748E-4C37-9A3D-669CF9D8C4EC Q36632693-B7C0D770-5773-4FE3-8182-8CC0C77E742D

P2860

Long-term course and effectiveness of combination therapy in Alzheimer disease

http://www.wikidata.org/entity/Q24642161

description

2008 nî lūn-bûn

@nan

2008 թուականին հրատարակուած գիտական յօդուած

@hyw

2008 թվականին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Long-term course and effectiveness of combination therapy in Alzheimer disease

@ast

Long-term course and effectiveness of combination therapy in Alzheimer disease

@en

Long-term course and effectiveness of combination therapy in Alzheimer disease

@nl

type

label

Long-term course and effectiveness of combination therapy in Alzheimer disease

@ast

Long-term course and effectiveness of combination therapy in Alzheimer disease

@en

Long-term course and effectiveness of combination therapy in Alzheimer disease

@nl

prefLabel

Long-term course and effectiveness of combination therapy in Alzheimer disease

@ast

Long-term course and effectiveness of combination therapy in Alzheimer disease

@en

Long-term course and effectiveness of combination therapy in Alzheimer disease

@nl

P1433

Q24642161-960A03DF-A287-419F-9DD1-60FEF43772FB

P1476

Q24642161-895EF8EF-5289-469D-90EA-C6408D89AC18

P2093

Q24642161-6291453C-2747-48A7-A900-F7A1475062E2

Q24642161-65500679-823B-4C08-A714-7225AD424BE7

Q24642161-9F07CF47-78B9-42B9-8BCE-74B0400F7286

P2860

Q24642161-01654794-704F-4EC5-A5FB-C098C83D4F1E

Q24642161-054BE247-D8C1-4049-9EA4-23A53281D903

Q24642161-05A5D3A2-0309-46ED-9AF2-3E63BE2B0FEE

Q24642161-0852878A-D13A-4F98-AEE8-B2385270545F

Q24642161-09138065-DF0D-4866-B22D-820BD7A357C2

Q24642161-0A661BD3-039A-4A58-A4EB-8EA4027F4D66

Q24642161-13237817-7AE2-4168-8221-7E56B3142DF2

Q24642161-18CABCC5-7858-4C38-B4C8-C34BC836EA39

Q24642161-1E6F75F5-B634-42CE-B99E-F91DFA3BAAA2

Q24642161-22376B99-DE4F-488E-8BD8-64DFB539E0B1

P304

Q24642161-D2EF770F-84E5-4767-A738-9D772B4E09C8

P31

Q24642161-25698B95-435E-4B5F-8563-4D6C90AD6235

P3181

Q24642161-9EE69412-7D89-47D8-95A3-DFA44B36E824

P356

Q24642161-9F0011B9-70E5-49D9-9CB6-94C70FA6C0AF

P407

Q24642161-0FA951FB-5C8F-46C6-A328-2817F2A499A0

P433

Q24642161-624DBCDB-093B-4134-98E0-C5F9D74BEE25

P478

Q24642161-14EC34E1-F027-43FF-B465-AF7C17D105DE

P50

Q24642161-9C052931-8B5B-487A-AA66-79B11BD40AED

P577

Q24642161-7C4FE034-8C62-4618-AB61-8BA6D2D916A0

P698

Q24642161-8FD029A8-A907-4233-ADC9-D3EC44FF757A

P921

Q24642161-ce7ad7ff-4f39-47ea-01e9-4ee370b1007e

Q24642161-e46d8167-4840-785e-e0f2-38c3e02635c1

P932

Q24642161-18E41A1F-3065-4BB8-B284-259E45D598A7

P3181

P356

WAD.0B013E31816653BC

P1433

Alzheimer Disease and Associated Disorders

P1476

Long-term course and effectiveness of combination therapy in Alzheimer disease

@en

P2093

John H Growdon

http://www.w3.org/2001/XMLSchema#string

Joseph J Locascio

http://www.w3.org/2001/XMLSchema#string

Lynn W Shaughnessy

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterase inhibitors for Alzheimer's disease

Memantine for dementia

Alzheimer Disease in the US Population

Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes.

Donepezil therapy in clinical practice: a randomized crossover study.

Effects of cholinesterase inhibitors on behavioural disturbances in Alzheimer's disease: a systematic review.

Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis.

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.

P304

209-221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1094942

http://www.w3.org/2001/XMLSchema#string

P356

10.1097/WAD.0B013E31816653BC

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18580597

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2718545

http://www.w3.org/2001/XMLSchema#string